As he settles into a new office at the Johns Hopkins Center for Transgender Health, medical director Devin O’Brien Coon describes the life-changing surgeries that are part of his daily routine and that signal a new era at Johns Hopkins Medicine.
Our mission is to blaze new trails in the fields of tissue engineering and immunoengineering while training tomorrow’s top researchers and accelerating the delivery of regenerative medicine technologies to patients.
As he settles into a new office at the Johns Hopkins Center for Transgender Health, medical director Devin O’Brien Coon describes the life-changing surgeries that are part of his daily routine and that signal a new era at Johns Hopkins Medicine.
Since arriving at Hopkins as assistant professor in July 2017, Jamie Spangler, a member of the TTEC team, has welcomed 14 lab members, taught the university’s first molecular immunoengineering course, and embarked on research collaborations in areas ranging from macular degeneration to diabetes.
Outside the traditional confines of academic disciplines, technological innovation and entrepreneurship are defining characteristics of the department of plastic and reconstructive surgery. Recently, our experts have launched at least three companies, including LifeSprout, co-founded by TTEC researcher Hai-Quan Mao.